91 Blue Ravine Rd
Tel: +1 916-985-7888
About Agilent Technologies
Premier Laboratory Partner for a Better World
Analytical scientists and clinical researchers worldwide rely on Agilent to help fulfill their most complex laboratory demands. Our instruments, software, services, and consumables address the full range of scientific and laboratory management needs—so our customers can do what they do best: improve the world around us.
Whether a laboratory is engaged in environmental testing, academic research, medical diagnostics, pharmaceuticals, petrochemicals, or food testing, Agilent provides laboratory solutions to meet their full spectrum of needs. We work closely with customers to help address global trends that impact human health and the environment and to anticipate future scientific needs. Our solutions improve the efficiency of the entire laboratory, from sample prep to data interpretation and management.
Customers trust Agilent for solutions that enable insights...for a better world.
611 articles about Agilent Technologies
Agilent Reports Second-Quarter Fiscal Year 2023 Financial Results
Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.72 billion for the second quarter ended April 30, 2023, an increase of 6.8% compared to the second quarter of 2022 and up 9.5% on a core(1) basis.
Agilent to Present at Jefferies and Goldman Sachs Healthcare Conferences
Agilent Technologies Inc. (NYSE: A) today announced that the company will participate in Q&A sessions at the Jefferies and Goldman Sachs healthcare conferences.
Agilent to Appeal Patent Office Decision on CRISPR gRNA Patents
Agilent Technologies Inc., announced the company intends to appeal the U.S. Patent and Trademarks Office Patent Trial and Appeal Board’s Final Written Decision in connection with the Inter Partes review of U.S. Patent Nos. 10,337,001 & 10,900,034.
Synthego Announces Invalidation of Agilent Patents in CRISPR Dispute
Synthego Corp. has announced a victory in its dispute with Agilent Technologies, Inc., regarding two of Agilent's patents which have been invalidated by a ruling of the Patent Trial and Appeal Board of the U.S. Patent and Trademark Office.
Agilent Announces Solutions Innovation Research Award to Dr. Jiangbin Ye
Agilent Technologies Inc. announced that Dr. Jiangbin Ye has received an Agilent Solutions Innovation Research Award.
Agilent to Announce Second-Quarter Fiscal Year 2023 Financial Results May 23
Agilent Technologies Inc. (NYSE: A) will release financial results and hold an earnings conference call for the second quarter of fiscal year 2023 after the stock market closes on Tuesday, May 23 at 1:30 p.m. PDT.
Agilent Showcases Comprehensive Cancer Portfolio Solutions at AACR 2023
Agilent Technologies Inc. (NYSE: A) announced today that it will highlight new cell analysis, genomics, digital pathology, and companion diagnostics solutions at the American Association for Cancer Research Annual Meeting , held April 14-19, 2023, in Orlando, Florida.
Agilent Announces NGS Assay for Comprehensive Genomic Profiling (CGP) for Advancing Precision Oncology
Agilent Technologies Inc. (NYSE: A) today announced the launch of the Agilent SureSelect Cancer CGP Assay designed for somatic variant profiling for a broad range of solid tumor types.
Agilent and PathAI Partner to Deliver AI-Powered Assay Development Solutions for Biopharma Research and Clinical Applications
Agilent Technologies Inc. (NYSE: A) today announced a strategic partnership with PathAI, a leading provider of AI-powered research tools and services for pathology, to deliver biopharmaceutical organizations a solution that combines Agilent’s assay development expertise and PathAI’s algorithm development capabilities.
Agilent Announces High-Performance Cary 3500 Flexible UV-Vis System
Agilent Technologies Inc. (NYSE: A) today announced the latest addition to the Cary 3500 UV-Vis Series with the release of the Agilent Cary 3500 Flexible UV-Vis System.
Agilent Announces Thought Leader Award to Dr. Chenli Liu
Agilent Technologies Inc. announced that Dr. Chenli Liu has been selected to receive an Agilent Thought Leader Award.
Agilent Presents 2023 Darlene Solomon Award to Victor Chang Cardiac Research Institute Scientist, Kathryn Wolhuter
Agilent Technologies Inc. announced that the recipient of the 2023 Darlene Solomon Award is Kathryn Wolhuter, Ph.D., a senior postdoctoral researcher studying coronary heart disease at the Victor Chang Cardiac Research Institute in Sydney, Australia.
SOPHiA GENETICS and Agilent Partner on Comprehensive Solution for Cancer Analysis
SOPHiA GENETICS is partnering with Agilent to offer a comprehensive solution for cancer analysis.
Agilent Announces Digital Pathology Scanner Distribution Agreement with Hamamatsu
Agilent Technologies Inc. announced it has partnered with Hamamatsu Photonics K.K., a leading provider of whole slide imaging systems, to incorporate their NanoZoomer range including the S360MD Slide scanner system into the Agilent end-to-end digital pathology solution.
Agilent Announces Acquisition of e-MSion, Early-Stage Company Behind ECD Technology that Helps Accelerate Drug Development
Agilent Technologies Inc. (NYSE: A) today announced the acquisition of e-MSion, an early-stage company behind the innovative electron capture dissociation (ECD) technology known as the ExD cell.
Agilent Announces Global Distribution Agreement with Proscia to Accelerate Data-Driven Precision Medicine
Agilent Technologies Inc. (NYSE: A) today announced a multi-year distribution agreement with Proscia ® – a leader in digital pathology – to offer a comprehensive digital diagnostic pathology system.
Agilent to Present at Barclays Global Healthcare Conference
Agilent Technologies Inc. (NYSE: A) today announced that Chief Financial Officer Bob McMahon will participate in a Q&A session at the Barclays Global Healthcare Conference in Miami Beach, Florida, on March 15 at 3:05 p.m. EST.
Agilent Reports First-Quarter Fiscal Year 2023 Financial Results
Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.76 billion for the first quarter ended January 31, 2023, an increase of 5% compared to the first quarter of 2022 and up 10% on a core(1) basis.
Agilent Announces Bravo NGS Automated Liquid Handling Platform with On-Deck Thermal Cycler
Agilent Technologies Inc. (NYSE: A) today announced the release of an on-deck thermal cycler (ODTC) that integrates with the Agilent Bravo NGS automated liquid handling platform.
Agilent Announces Cell Analysis Workflow Automation for Immuno-Oncology, Virology, and Vaccine Development Markets
Agilent Technologies Inc. announced their xCELLigence RTCA HT platform now integrates with the BioTek BioSpa 8 Automated Incubator.